BioMimetic Therapeutics (BMTI) 2.54 0.01
BioMimetic Therapeutics, Inc.
(BMTI) 2.54 0.01
(BMTI) 2.54 0.01
| Last Trade: | 2.53 | Day Range: | 2.48 - 2.55 |
| Trade Time: | 04:05PM | 52wk Range: | 1.87 - 7.57 |
| Prev. Close: | 2.52 | Market Cap: | 71.34M |
| Open: | 2.50 | Div Yield: | 0 |
| Volume: | 48765 | PE: | -20 |
| EPS: | -1.12 |
The Latest On BMTI
JP Morgan Reiterates BioMimetic Therapeutics Neutral 1/4/12 2:05pm
Wedbush Downgrades BioMimetic Therapeutics to Neutral 1/4/12 12:44pm
End-of-Day Market Summary for January 3, 2012 1/3/12 5:17pm
5 Stocks for Wednesday's Trading 11/22/11 6:47pm
Notable Call Options Activity in BioMimetic Therapeutics 10/5/11 10:39am
Notable Call Options Activity in BioMimetic Therapeutics 8/26/11 3:18pm
NASDAQ Stocks Hitting 52-Week Lows 7/12/11 10:21am
5 Stocks for Wednesday's Trading 11/22/11
5 Stocks for Wednesday's Trading 11/22/11
Benzinga's Top Downgrades 7/1/11
Trade BMTI
NOW!
NOW!
Partner Headlines
Press Releases
BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results 5/9/12 Business Wire
BioMimetic Therapeutics, Inc. Reports Fourth Quarter and Year-End 2011 Earnings Results 3/13/12 Business Wire
BioMimetic Therapeutics Announces Approval to Market GEM 21S® in the European Union 1/3/12 Business Wire
BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter from FDA 1/3/12 Business Wire
From Benzinga's Newsdesk
- 05:01 PM AptarGroup Will Acquire Stelmi Group for About $207M
- 05:00 PM MSCI Inc. Announces Appointment of New Chief Financial Officer
- 4:59 PM Allegheny Tech Files Automatic Mixed Securities Shelf
- 4:59 PM NCI Building Systems Reports Q2 EPS $(0.45) vs $(0.39) Est, Sales $250.2M vs $250.20M Est
- 4:53 PM Carlyle Seeks Investments from China State Bodies -Bloomberg
- 4:52 PM Fed's Rosengren Calls for More Easing; Doesn't See Employment Improvement, Sees Inflation Below 2% with Significant Downside Risks; Expects 2.3% Economic Growth This Year
- 04:49 PM Neo Material Shareholders Approve Molycorp Acquisition
- 4:46 PM Teva Begins Trading on NYSE
- 04:45 PM Triumph Group Says All Criminal Proceedings in MS Closed; Civil Actions Still Pending
- 4:42 PM Eagle Materials Files Automatic Mixed Securities Shelf
- 4:41 PM BioMarin Pharma Files Common Stock Shelf Registration
- 4:40 PM Applied Materials Entered Into Amendment, Extension to Credit
- 4:37 PM F5 Reports Resignation of EVP of Worldwide Sales, Names Feringa Successor
- 4:32 PM Google Told 500K Users About DNSChanger Infections on Devices -Bloomberg
- 4:20 PM Moody's Downgrades Danish Financial Institutions; Outlook Stable for Most Banks -Reuters
Brain Trust
- Copart, Inc: Bull or Bear?
- New Contract Signing Highlights Mattersight's Coaching Analytics
- Syntroleum Says It Defends Renewable Fuels Intellectual Property Rights
- Starwood to Redeem Its 6.25% Senior Notes Due 2013
- ETF Pair Trade From New Constructs (AAPL, XLK, FDN, PXN, AMZN)
- Biostar Pharmaceuticals Provides Update Regarding Gel Capsule Safety Issues
- Endologix Announces Public Offering of 2.7 Million Shares of Common Stock
- Amerigroup Receives Upgrade to Senior Debt Rating
- Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
- Tengion Announces 1-for-10 Reverse Stock Split
- Is Facebook Secretly Cloning the iPhone 5?
- Was IBM Smart to Ban Siri?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- 5 Small-Cap Short Ideas
- Earnings Scheduled For May 29
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- James Altucher Article Sends Neonode Soaring
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Social Media Chatter on Dell Around Its Earnings Report
- Opera Would Be "Another Stupid Acquisition" for Facebook, Says Analyst
